BBC: First cancer 'living drug' gets go-ahead, por James Gallagher

The US has approved the first treatment to redesign a patient's own immune system so it attacks cancer.
The regulator - the US Food and Drug Administration - said its decision was a "historic" moment and medicine was now "entering a new frontier".
The company Novartis is charging $475,000 (£367,000) for the "living drug" therapy, which leaves 83% of people free of a type of blood cancer.
Doctors in the UK said the announcement was an exciting step forward.

Seguir leyendo,
EN:

http://www.bbc.com/news/health-41094990